Allegro reports positive safety data for its injectable osteoarthritis treatment in three preclinical studies
Allegro NV, a biomedical company developing a transformative nanotechnology-based treatment for degenerative joint disease, announced recently that hydrocelin (ALG-001), its...
Read More